Association Study Between VDR Gene Polymorphisms and Risk and Features of MG in Han Chinese Population
Launched by BEIJING TONGREN HOSPITAL · May 15, 2022
Trial Information
Current as of May 24, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Clinical diagnosis of myasthenia gravis.
- • Han Chinese population.
- • Must be able to complete a 2-year follow-up visit.
- Exclusion Criteria:
- • Clinical data collection can not be completed.
- • Poor compliance.
About Beijing Tongren Hospital
Beijing Tongren Hospital, affiliated with Capital Medical University, is a leading medical institution in China known for its comprehensive clinical services and research initiatives. With a strong focus on ophthalmology and a commitment to advancing healthcare through innovative clinical trials, the hospital leverages its expertise in various specialties to contribute to medical knowledge and improve patient outcomes. The institution is dedicated to adhering to the highest ethical standards and regulatory requirements, ensuring the integrity and reliability of its research endeavors. Through collaboration with national and international partners, Beijing Tongren Hospital aims to enhance the quality of care and foster advancements in medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, , China
Beijing, Beijing, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials